Sunshine Biopharma, Inc.
SBFM
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.86% | -23.44% | -1.97% | -9.69% | 25.75% |
| Total Receivables | 0.59% | 15.95% | -16.74% | 15.83% | 4.13% |
| Inventory | -7.95% | -2.25% | -4.21% | 8.03% | 9.80% |
| Prepaid Expenses | -22.62% | -22.55% | 80.84% | -53.00% | -4.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.73% | -7.71% | -3.98% | 0.42% | 13.77% |
|
|
|||||
| Total Current Assets | 23.73% | -7.71% | -3.98% | 0.42% | 13.77% |
| Net Property, Plant & Equipment | -8.45% | -7.99% | -5.81% | -7.35% | 7.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -3.95% | 1.50% | -5.97% | -19.33% | -22.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 0.00% | 0.00% |
| Total Assets | 20.42% | -7.14% | -4.47% | -1.50% | 9.52% |
|
|
|||||
| Total Accounts Payable | -4.94% | -9.87% | -7.71% | 27.93% | -4.52% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.20% | -2.97% | -1.15% | -1.98% | 3.97% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 90.70% | -46.61% | 5.75% |
| Total Other Current Liabilities | 0.00% | 0.00% | 90.70% | -46.61% | 5.75% |
| Total Current Liabilities | -4.41% | -8.78% | -3.12% | 19.33% | -3.27% |
|
|
|||||
| Total Current Liabilities | -4.41% | -8.78% | -3.12% | 19.33% | -3.27% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.17% | -10.25% | -6.27% | -9.88% | -2.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -4.97% | -8.90% | -3.39% | 16.04% | -3.15% |
|
|
|||||
| Common Stock & APIC | 8.05% | 0.00% | 0.74% | 0.00% | 3.91% |
| Retained Earnings | -2.05% | -1.66% | -2.94% | -1.23% | -2.52% |
| Treasury Stock & Other | -91.93% | -425.73% | 79.64% | -214.25% | 134.93% |
| Total Common Equity | 28.00% | -6.61% | -4.80% | -5.79% | 13.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 28.00% | -6.61% | -4.80% | -5.79% | 13.14% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.98% | -6.61% | -4.80% | -5.78% | 13.14% |
|
|
|||||